[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Redeye_ Avatar @Redeye_ Redeye

Redeye posts on X about $geno, $ver, topics, $helio the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence cryptocurrencies XXX% stocks XXXX% exchanges XXXX% finance XXXX%

Social topic influence $geno #2, $ver #7, topics #2455, $helio 0.27%, $ptrk 0.27%, $de 0.27%, $bico 0.27%, $avt 0.27%, currency 0.27%, longterm XXXX%

Top accounts mentioned or mentioned by @smarteyeab @longriver_hk @safelloab @taocat_agent @10_ch_10 @tomasotterbeck @thome_fole @fredrikkjell @michaelgielkens @simplerinvestor @chad_pumpiano @saeschinv @timontti

Top assets mentioned GenomeFi (GENO) HELIO AI (HELIO) Deere & Company (DE) Biconomy (BICO) Aventus (AVT) Coldstack (CLS)

Top Social Posts #

Top posts by engagements in the last XX hours

"Redeye comments on Heliospectras proposed SEK49.5m rights issue partly secured by main shareholder Weland Stl AB (63% ownership). $HELIO"
X Link @Redeye_ 2025-09-30T09:24Z 14.5K followers, 1211 engagements

"Physitrack is trading below Redeye's Base Case. We spoke with our analyst regarding the the current expectations for the following report Physitrack's strategy to convert the Nexa/Physitrack partnership into broader Wellness traction and other key topics. This is a premium article included in our paid plans from SEK 99/month. $PTRK"
X Link @Redeye_ 2025-10-14T08:19Z 14.5K followers, XXX engagements

"Top Picks provides an update following a change in the Alternative Picks list taking profit on a position that has played out as expected. Top Picks is included in our premium memberships from SEK 349/month. $DE"
X Link @Redeye_ 2025-10-15T08:43Z 14.5K followers, XXX engagements

"BICO Group is trading below Redeye's Base Case. We spoke with our analyst regarding BICO's business model key challenges and other key topics. This is a premium article included in our paid plans from SEK 99/month. $BICO"
X Link @Redeye_ 2025-10-07T08:24Z 14.5K followers, 1151 engagements

"Redeye comments on a preliminary release ahead of its full report on XX October 2025 where AVTECH announced Q3 2025 net sales of SEK12.3 million representing XX% year-over-year growth despite adverse currency movements. $AVT"
X Link @Redeye_ 2025-10-06T06:16Z 14.5K followers, XXX engagements

"Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case. $GENO"
X Link @Redeye_ 2025-08-13T07:19Z 14.5K followers, 1127 engagements

"Redeye comments on Verve's announced acquisition. $VER"
X Link @Redeye_ 2025-09-17T15:10Z 14.5K followers, 1329 engagements

"Redeye comments on Verve Groups Q2 2025 results and the lowered full-year guidance. $VER"
X Link @Redeye_ 2025-08-15T07:12Z 14.5K followers, 1789 engagements

"Redeye updates its valuation of Verve which within two days announced two acquisitions that complement each other well. $VER"
X Link @Redeye_ 2025-09-22T06:16Z 14.5K followers, 1412 engagements

"Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO"
X Link @Redeye_ 2025-07-02T09:46Z 14.5K followers, 1443 engagements

"Redeye comments on BeammWave formalising its long-standing collaboration with Nitto Denko through a Joint Development Agreement aiming to strengthen their joint efforts in high-frequency communications and co-develop products. $BEAMMW"
X Link @Redeye_ 2025-08-01T06:47Z 14.5K followers, 1429 engagements

"Redeye's view of Genovis Q2 report is balanced sales were largely in line but profitability was softer than we had estimated. $GENO"
X Link @Redeye_ 2025-08-12T08:49Z 14.5K followers, 1005 engagements

"Redeye comments on the now confirmed partnering with industry giant Quest Diagnostics for channel coverage of Devysers RHD test kit. $DVYSR"
X Link @Redeye_ 2025-08-28T14:24Z 14.5K followers, 1211 engagements

"Redeye is positive about the results from CLSs study at Skne University Hospital. $CLS"
X Link @Redeye_ 2025-10-08T09:55Z 14.5K followers, XXX engagements